PhD in pharmacology, University of Wisconsin, Madison
Bachelor of Arts in biology, cum laude, University of California, San Diego
Current teaching assignments include:
PharmSci 530 “Foundations of Cellular Regulation” (instructor of record)
PharmSci 579 “Introduction to Research” (two lectures)
Dr. Meier also serves as an occasional guest lecturer and helps out in many other courses.
Dr. Meier’s laboratory studies the molecular pharmacology of signal transduction, with a recent focus on GPCR receptor-mediated mechanisms by which omega-3 fatty acids inhibit the growth of certain cancers. Model systems include several types of cancer cells, including prostate and breast cancer. There is particular interest in lysophosphatidic acid (LPA), a ligand for GPCRs, as an autocrine and paracrine mediator of growth and inflammation. Other interests include proteins involved in adhesion signaling (e.g., FAK, CCNs) and their regulation by LPA, epidermal growth factor, and other growth factors.
Gibbs, T.C. and Meier, K.E. Expression and regulation of phospholipase D isoforms in mammalian cell lines. J. Cell Physiol. 182: 77-87, 2000.
Gibbs, T.C., Xie, Y., and Meier, K.E. Regulation of expression of Edg family receptors in human prostate cancer cell lines. Ann. N.Y.A.S. 905: 290-293, 2000.
Ku, H., and Meier, K.E. Phosphorylation of paxillin via the ERK mitogen-activated protein kinase cascade in EL4 thymoma cells. J. Biol. Chem. 275: 11333-11340, 2000.
Xie, Y., and Meier, K.E.: Assays for phospholipase D metabolites in mammalian cells. Meth. Enzymol. 344: 294-305, 2001.
Xie, Y., Gibbs, T.C., and Meier, K.E.: Lysophosphatidic acid as an autocrine and paracrine mediator. Biochim. Biophys. Acta, 1582: 270-281, 2001.
Xie, Y., Gibbs, T.C., Mukhin, Y., and Meier, K.E.: Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells. J. Biol. Chem. 277: 32516-32526, 2002.
Xie, Y., and Meier, K.E.: Lysophospholipase D and its role in LPA production. Cell Signal. 16: 975-981, 2004.
Zhang, Z., and Meier, K.E.: New assignments for multi-tasking signal transduction inhibitors. Mol. Pharm. 69: 1510-1512, 2006.
Zhang, Z., Liu, Z., and Meier, K.E.: Lysophosphatidic acid production and response in a corneal epithelial cell line. Am. J. Physiol. Cell Physiol. 291: C1089-C1098, 2006.
Han, S., Knoepp, S.M., Hallman, M., and Meier, K.E.: RasGRP confers the phorbol ester-sensitive phenotype to EL4 lymphoma cells. Mol. Pharm. 71: 314-322, 2007.
Snider, A.J., and Meier, K.E.: Receptor transactivation cascades. Am. J. Physiol. Cell Physiol. 292: C1-C3, 2007.
Knoepp, S.M., Chahal, M.S., Xie, Y., Zhang, Z., Brauner, D.J., Hallman, M.A., Robinson, S.A., Han, S., Imai, M., Tomlinson, S., and Meier, K.E.: Effects of phospholipase D2 expression on adhesion and tumorigenesis in EL4 thymoma cells. Mol. Pharm. 74: 574-584, 2008.
Han, S., and Meier, K.E. Integrated modulation of phorbol ester-induced Raf activation in EL4 lymphoma cells. Cellular Signaling 21: 793-800, 2009.
Gibbs, T.C., Rubio, M.V., Zhang, Z., Xie, Y., Kipp, K.R., and Meier, K.E.: Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells. Prostate 69: 1493-1506, 2009.
Jones, A.C., Zhang, Z., Xie, Y., and Meier, K.E.: Epidermal growth factor increases lysophosphatidic acid production in human ovarian cancer cells: Roles for phospholipase D2 and receptor transactivation. Am. J. Physiol. Cell Physiol. 298: C163-C170, 2010.
Chahal, M.S., Brauner, D, and Meier, K.E.: Effects of phospholipase D2 on EGF receptor response in EL4 lymphoma cells. Pharmaceuticals 3: 2045-2058, 2010.
Zhang Z, Knoepp SM, Sansbury HM, Ku H, Xie Y, Hallman M, Meier KE. Differential expression of FAK and Pyk2 in phorbol ester-sensitive and -resistant EL4 thymoma cells. Clin. Expt. Metastasis 28, 551-565, 2011.
Park, J.J., Rubio, M.V., Zhang, Z., Um, T., Xie, Y., Knoepp, S.M., Snider, A.J., Gibbs, T.C., and Meier, K.E.: Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells. The Prostate 72, 1595-1610, 2012.
Liu, Z., Hopkins, M., Zhang, Z., Quisenberry, C.R., Fix, L.C., Galvan, B.M., and Meier, K.E. Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells. J. Pharm. Exp. Ther. 352, 380-394, 2015.